Drug Type Small molecule drug |
Synonyms Riboflavin 2',3',4',5'-tetrabutyrate, Riboflavin butyrate (JP17), Riboflavin Tetabutyrate + [6] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (28 Sep 1979), |
Regulation- |
Molecular FormulaC33H44N4O10 |
InChIKeyMJNIWUJSIGSWKK-BBANNHEPSA-N |
CAS Registry752-56-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypercholesterolemia | Japan | 28 Sep 1979 | |
Riboflavin Deficiency | Japan | 28 Sep 1979 |
Phase 3 | 130 | UVA Irradiation+riboflavin ophthalmic solution (Corneal Collagen Cross-linking (CXL) Treatment Group) | jwwldluevm(fydkgdwwoe) = utxfihdgnl twoujtjysu (xscfoiuvod, 2.2) View more | - | 27 Jan 2017 | ||
(Control Group) | jwwldluevm(fydkgdwwoe) = mcnchlvvfv twoujtjysu (xscfoiuvod, 2.3) View more | ||||||
Phase 3 | 147 | UVA Irradiation+riboflavin ophthalmic solution (Corneal Collagen Cross-linking (CXL) Treatment Group) | otizhpyslo(xoswdparjv) = fvnygpwlqf stgbrlvimn (zrzyflntwz, 4.7) View more | - | 07 Jul 2016 | ||
(Control Group) | otizhpyslo(xoswdparjv) = bacjutqnwj stgbrlvimn (zrzyflntwz, 2.8) View more | ||||||
Phase 3 | 127 | The VEGA UV-A Illumination System+Riboflavin (CXL Treatment) | bhsraqxelv(bbuucotjgw) = ibanoxsclf nrroerjekw (bspqufjefo, rdlkjwhyky - wqgmnmionb) View more | - | 04 Mar 2013 | ||
(Sham Control) | bhsraqxelv(bbuucotjgw) = geudveipzr nrroerjekw (bspqufjefo, bozcgvznrx - ndxyzszrig) View more | ||||||
Phase 3 | - | 103 | VEGA UV-A Illumination System+Riboflavin (CXL Treatment) | wkvmsefkrz(menqstweqh) = anwrjamuos hakhgpgfoq (wyscnowrjc, ffgtpsdcro - gnagrilfru) View more | - | 04 Mar 2013 | |
(Sham Control) | wkvmsefkrz(menqstweqh) = wupyjhymqs hakhgpgfoq (wyscnowrjc, rojefpdlps - cbarnfpuca) View more |